Democritus University of Thrace (DUTH)
Τα απώτερα αποτελέσματα της ολικής θυρεοειδεκτομής με ή χωρίς χορήγηση καλσιτονίνης στην οστική μάζα ασθενών με καλοήθεις θυρεοειδοπάθειες
Abstract
dc:descriptionTotal thyroidectomy consist the selective treatment of all non - malignant diseases of the thyroid gland. However, the consequence of this practice is to dispossess the human organism of the C cells of the thyroid gland. These cells secrete the biological active monomer of calcitonin, which is a hormone with mainly an osteoclastic activity. The objective of the present study was to determine the impact of the total thyroidectomy as well as of the perdition of the thyroid calcitonin to the bone mass in patients with non - malignant diseases of the thyroid gland. From the 198 patients that were studied, 35 were males (average age: 48,85 years) and 163 females (average age: 47,63 years). The pre - menopausal patients were 112 (average age: 40,68 years) and the post-menopausal 51 (average age: 62,40 years). The bone density of the collum of the thighbone and the lumbar region of the spinal column were determined in all patients preoperational. Moreover, the alteration of the bone density was determined six and twelve months after the total thyroidectomy. The patients were graded in four groups according to their disease (Grave’s disease, toxic multinodular goiter, multinodular goiter and cold thyroid nodule). Additionally, the enrolled women were separated in premenopausal and postmenopausal groups. Exogenous Solomon calsitonin was administered as intranasal spray to the half of the above mentioned patients, post operational. It was observed that: 1) total thyroidectomy significantly reduces the bone density of the collum of the thighbone in premenopausal women with multinodular goiter, the bone density of the lumbar region of the spinal columnin premenopausal women with Grave’s disease and of the lumbar region of the spinal column in postmenopausal women with Grave’s disease. 2) The exogenous administration of sCT leads to a significant increase of the bone density in the lumbar region of the spinal column in men with Grave’s disease and multinodular goiter, in the bone density of the collum of the thighbone in pre - menopausal women with multinodular goiter, in the lumbar region of the spinal column in premenopausal women with cold thyroid nodule and in premenopausal women with toxic multinodular goiter. 3) The postoperational administration of sCT increases with statistical significance the bone density both of the collum of the thighbone and the lumbar region of the spinal column in pre - menopausal women with toxic goiter, compared with the group of postmenopausal women, who received sCT and had the same thyroid disorders. In contrary, it was observed that postmenopausal women with toxic goiter, who did not receive sCT, had a significant increase in the bone density of the lumbar region of the spinal column compared with the pre - menopausal women, with the same thyroid disorders and with no sCT treatment. It is concluded that total thyroidectomy influence adversely the bone density in patients with non - malignant thyroid diseases, while the postoperational administration of sCT increases the bone density, inhibits the additional loss of the bone mass in post - menopausal women and protect pre - menopausal women from the risk of osteoporosis
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2003
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stamopoulou, Sotiria
- Σταμοπούλου, Σωτηρία
Subjects
dc:subject × 17- Καλσιτονίνη
- Οστική πυκνότητα
- Καλοήθεις θυρεοειδοπάθειες
- Ολική θυρεοειδεκτομή
- Οστεοπόρωση
- Μετεμμηνοπαυσιακή οστεοπόρωση
- Calcitonin deficiency
- Osteoporosis
- Bening thyroid diseases
- Total thyroidectomy and bone density
- Postmenopausal osteoporosis
- Bone mineral density
- Bone mass
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/17501